Back
ESC Premium Access

Use of multiple biomarkers to improve CHA2DS2-VASc and HAS-BLED scores in the prediction of thromboembolic and bleeding events.

Session: Outcomes in atrial fibrillation: room for improvement?
Topic: Biomarkers
Speaker: Associate Professor F. Marin (Murcia, ES)
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Associate Professor Francisco Marin

Virgen of the Arrixaca University Hospital, Murcia (Spain)
3 presentations
0 follower

5 more presentations in this session

Stroke and cardiovascular outcomes for patients with atrial fibrillation in the community - an opportunity for improvement?

Speaker: Doctor K. Poppe (Auckland, NZ)

Access
Abstract
Like
Thumbnail

Thoracoscopic left atrial appendectomy can prevent patients with atrial fibrillation from thromboembolism without anticoagulants

Speaker: Doctor T. Inoue (Tokyo, JP)

Access
Abstract
Slides
Like
Thumbnail

Evaluation of ABC-stroke and CHA2DS2-VASc ischemic scores in real-world atrial fibrillation patients receiving oral anticoagulation treatment.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Access
Abstract
Slides
Like
Thumbnail

Predictive value of the CHA2DS2-VASc score for cardiovascular death in comparison with stroke in patients with atrial fibrillation: The Fushimi AF Registry

Speaker: Doctor Y. An (Kyoto, JP)

Access
Abstract
Like
Thumbnail

Performance of the CHA2DS2-VASc score in patients with atrial fibrillation and recent cancer

Speaker: Doctor M. D'Souza (Copenhagen, DK)

Access
Abstract
Like
Thumbnail

Access the full session

Outcomes in atrial fibrillation: room for improvement?

Speakers: Associate Professor F. Marin, Doctor K. Poppe, Doctor T. Inoue, Doctor M. Esteve Pastor, Doctor Y. An...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources